Newly Approved Drug Therapies (447): Synagis, MedImmune

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: Synagis

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: MedImmune
Approval Status: Approved June 1998
Treatment for: respiratory syncytial virus (RSV)

General Information

Synagis has been approved for the prevention of serious lower respiratory tract disease in pediatric patients at high risk of RSV disease. Synagis is the first monoclonal antibody to be licensed for any infectious disease. It is injected intramuscularly in a doctor's office.

Back to Drug Listing

Drug listing last updated on June 20, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]